The Association of Indian Medical Device Industry has raised concerns over the government’s draft notification on medical device testing fees and labelling norms. AiMeD’s Forum Coordinator Rajiv Nath said that capping testing fees without consulting National Accreditation Board for Testing and Calibration Laboratories-accredited labs could affect
New Delhi, : In a significant step towards improving the regulatory environment for India’s medical devices sector, NITI Aayog and the Department for Promotion of Industry and Internal Trade (DPIIT) have initiated measures to decriminalise minor offences and rationalise penalties under existing regulatory frameworks. The
New Delhi, : In a significant reform aimed at improving ease of doing business and reducing regulatory burden, the Government of India has advanced the Jan Vishwas Bill, which seeks to rationalise compliance requirements and decriminalise minor offences across sectors, including healthcare. The move is
New Delhi, 17 November 2025: The Association of Indian Medical Device Industry (AiMeD) has welcomed the Government of India’s landmark decision to withdraw multiple Quality Control Orders (QCOs) imposed in recent years on essential raw materials across polymer, plastic, textile, and chemical value chains. The
